10-K: Quantum Computing Inc. 2025 Annual Report: Growth, Acquisitions, Capital
Annual Report
Quantum Computing Inc. reported an 83% increase in total revenue for 2025, driven by product sales and strategic acquisitions, while continuing to incur significant operating losses and addressing internal control weaknesses.
Summary
- Quantum Computing Inc. (QCi) is an American company focused on integrated photonics and non-linear quantum optics to develop machines for quantum computing, machine learning, remote sensing, imaging, and cybersecurity applications.
- QCi's products, including the Entropy Quantum Computer (EQC), are designed to operate at room temperature and low power, differentiating them from cryogenic quantum systems.
- The company substantially completed the buildout of its state-of-the-art Thin Film Lithium Niobate (TFLN) chip research and development, prototyping, and small-batch manufacturing facility in Tempe, AZ, in March 2025.
- QCi acquired Luminar Semiconductor, Inc. (LSI) in February 2026 for $110 million in cash, broadening its photonic chip design and manufacturing capabilities.
- New products launched include the Dirac-3 EQC in Q1 2024 and Neurawave, a photonics-based reservoir computer, in November 2025.
- Total revenue increased 83% to $682 thousand in 2025 from $373 thousand in 2024, primarily driven by successful sales of vibrometer and quantum networking devices.
- The net loss decreased to $18.674 million in 2025 from $68.542 million in 2024.
- QCi raised $1,475.1 million in net proceeds through private placements of equity during 2025.
- The company reported an accumulated deficit of $219.2 million as of December 31, 2025.
- Material weaknesses in internal control over financial reporting were identified as of December 31, 2025, although previously identified weaknesses related to revenue recognition and accounting policies were remediated.
- QCi is involved in ongoing legal proceedings, including a securities class action lawsuit and multiple shareholder derivative actions.
Sentiment
Score: 7
Explanation: StockSavvy.ai views this as a positive report due to significant revenue growth, a substantial capital raise, and strategic acquisitions that strengthen the company's technological foundation, despite ongoing operating losses and internal control challenges typical for an early-stage, high-growth technology company.
Positives
- Total revenue increased 83% year-over-year to $682 thousand in 2025, up from $373 thousand in 2024.
- Product revenue saw a substantial increase of 1,063% in 2025, driven by successful sales of vibrometer and quantum networking devices.
- Successfully raised $1,475.1 million in net proceeds from equity private placements in 2025, significantly strengthening liquidity and capital resources.
- Strategic acquisition of Luminar Semiconductor, Inc. (LSI) in February 2026 for $110 million, enhancing photonic chip design and manufacturing capabilities and supporting the technology roadmap.
- Completion of the TFLN chip R&D and small-batch manufacturing facility in Tempe, AZ, in March 2025, with plans for a higher volume manufacturing facility (FAB 2).
- Launch of new products: Dirac-3 EQC in Q1 2024 and Neurawave (photonics-based reservoir computer) in November 2025, expanding product offerings.
- Net loss decreased significantly by 73% from $68.542 million in 2024 to $18.674 million in 2025.
- Interest and other income, net, increased by 4,798% to $20.718 million in 2025 from $423 thousand in 2024, reflecting higher cash balances from financing activities.
- Remediation of previously identified material weaknesses in internal controls related to revenue recognition and insufficient written policies and procedures for accounting and financial reporting.
Negatives
- Gross profit decreased by 40% to $67 thousand in 2025, with the gross profit margin falling from 30% in 2024 to 10% in 2025, largely due to higher direct labor expenses for new hardware product assembly and testing.
- Operating expenses increased significantly by 96% to $51.144 million in 2025, driven by higher research and development, sales and marketing, and general and administrative expenses.
- The company has a history of operating losses and an accumulated deficit of $219.2 million as of December 31, 2025, and expects to incur significant expenses and continuing losses for the foreseeable future.
- Identified material weaknesses in internal control over financial reporting as of December 31, 2025, related to the control environment, risk assessment process, and IT general controls.
- Ongoing securities class action lawsuit and multiple shareholder derivative actions alleging violations of the Exchange Act and breaches of fiduciary duties, which could result in substantial costs and divert management attention.
- The business model is unproven, and commercial adoption of quantum computing technology is uncertain and may never occur, posing a fundamental risk to long-term success.
- Reliance on a single supplier for certain materials and concentration of TFLN Optical Chips manufacturers in China and East Asia expose the company to geopolitical tensions, trade restrictions, and supply chain disruptions.
- The quantum computing industry is highly competitive, with larger, well-established technology companies and sovereign nations investing heavily, making it challenging for QCi to compete effectively.
- Future capital requirements are significant for R&D and manufacturing expansion, and additional financing may result in dilution to stockholders or be unavailable on acceptable terms.
- The company's ability to use net operating loss carryforwards and other tax attributes may be limited due to ownership changes, potentially increasing future income tax liability.
Risks
- The company is in its early stages with a limited operating history, making it difficult to forecast future results of operations.
- A history of operating losses and an expectation to incur significant expenses and continuing losses for the foreseeable future, with no certainty of achieving or sustaining profitability.
- The business model is unproven and may never allow the company to cover its costs.
- Inability to scale the business quickly enough to meet customer and market demand, which could adversely affect financial condition and results of operations.
- Commercial adoption of quantum computing technology is uncertain and may never occur, and the company has no experience in producing large quantities of its products.
- Products may contain defects in design and manufacture that may cause them to not perform as expected or require repair and design changes, potentially leading to liability.
- Failure to manage growth effectively could harm the business, results of operations, and financial condition.
- Requires a significant amount of cash for expenditures and may need additional capital sooner than planned, with no assurance that additional financing will be available on acceptable terms.
- Ability to use net operating loss carryforwards and other tax attributes may be limited in connection with ownership changes.
- Significant barriers in developing and manufacturing products, including the need to invent and develop new technology, which may not be overcome in a timely or cost-effective manner.
- Inability to reduce production costs sufficiently, which may prevent competitive pricing of quantum systems.
- Products and services may fail to deliver customer value to a broader range of customers than classical approaches, hindering market acceptance.
- The quantum computing industry is highly competitive, and the company may not be successful in competing or establishing confidence among partners and customers.
- Reliance on access to high-performance third-party classical computing through public clouds, with risks of connectivity issues or changes in relationships with providers.
- Dependence on certain suppliers, with failure to maintain relationships or replace them potentially having a material adverse effect on business.
- Acquisitions or divestitures could result in adverse impacts on operations, including integration challenges, diversion of management attention, and unexpected liabilities.
- TFLN Optical Chips manufacturers, suppliers, and distributors are concentrated primarily in China and other parts of East Asia, exposing the company to geopolitical uncertainty and supply chain disruptions.
- Inability to attract, retain, and motivate key associates, especially those with highly technical skill sets, could adversely affect the business.
- Competitors may achieve technological breakthroughs that render the company's quantum computing systems obsolete or inferior.
- The quantum computing industry is in its early stages and volatile, and if it does not develop or develops slower than anticipated, business growth will be harmed.
- Experience of service disruptions, outages, defects, and other performance and quality problems with quantum computing products and services, or reliance on public cloud infrastructure.
- Future growth and success depend on the ability to sell effectively to government entities and large enterprises, which involve longer sales cycles and specific risks.
- Quantum computing systems may not be compatible with some or all industry-standard software and hardware in the future.
- Cybersecurity risks and the failure to maintain the integrity of data could expose the company to data loss, litigation, and harm to reputation.
- Unfavorable conditions in the industry or global economy could limit business growth and negatively affect results of operations.
- Government actions and regulations, such as tariffs and trade protection measures, especially in China and the United States, may adversely impact the business.
- Potential to become subject to legal proceedings that could have a material adverse impact on financial position and results of operations.
- Material weaknesses in internal control over financial reporting, which may result in material misstatements or failure to meet periodic reporting obligations.
- Stock price has been and may continue to be volatile or may decline regardless of operating performance.
- Future sales of shares of common stock, or the perception that these sales may occur, may depress the stock price.
- Delays in filing financial reports, internal control weaknesses, and restatements could hinder Form S-3 eligibility.
- Shares of currently issued and outstanding stock may become freely tradable pursuant to Rule 144 and may dilute the market for shares.
- No current intention to pay dividends on common stock, meaning return on investment depends solely on stock price appreciation.
- Experience dilution of ownership interest due to the future issuance of additional shares of common stock.
- Executive officers and directors possess significant voting power, limiting influence on corporate matters.
- Articles of incorporation grant the Board the power to issue additional shares of common and preferred shares and to designate other classes of preferred shares, all without stockholder approval.
Future Outlook
QCi expects product revenues to continue to increase and anticipates future generations of its reservoir computing machines to introduce greater performance and scalability, enabling participation in large language model (LLM) training and other applications. The company's longer-term product development plan involves migrating current product designs to Thin Film Lithium Niobate (TFLN) optical integrated circuits. QCi expects to incur additional losses and higher operating expenses for the foreseeable future as it continues to invest in research and development, go-to-market programs, and integration/scaling costs associated with the Luminar Semiconductor acquisition. Management believes existing cash, cash equivalents, and investments will be sufficient to meet working capital and capital expenditure needs for at least the next twelve months, but may pursue opportunistic capital raising or refinancing transactions.
Management Comments
- "Our vision is to lead the revolution in photonics and quantum information technology with scalable, accessible, and affordable solutions to bring quantum technology into real-world application to solve real-world problems."
- "We believe that these emerging approaches will create an opportunity for new materials and methods that can meet the growing demand for scalable performance and power efficiency."
- "We anticipate that our EQC may enable us to develop and produce multiple generations of quantum machines with increasing computational power, scalability, and speed."
- "We anticipate that future generations of the RC will introduce greater performance and scalability, which will enable the RC to participate in LLM training and other applications."
- "We believe that our Core Photonics Technology applications offer practical, cost-effective solutions that can materially advance the adoption of quantum machines across several market segments."
- "We believe QCi is well-positioned to benefit from this forecasted increase in demand [for TFLN and PIC markets]."
- "We believe that our existing cash, cash equivalents and investments will be sufficient to meet our working capital and capital expenditure needs for at least the next twelve months, although we may choose to take advantage of opportunistic capital raising or refinancing transactions at any time."
- "We are committed to maintaining a strong internal control environment and believe that these remediation efforts will represent significant improvements in our control environment."
Industry Context
StockSavvy.ai notes that Quantum Computing Inc. operates in a nascent but rapidly growing market for quantum computing and photonics, with market size estimates for high-performance computing reaching $53.6 billion by 2027 and enterprise quantum computing projected to hit $18.3 billion by 2030. The company's focus on room-temperature, low-power photonic quantum systems differentiates it from competitors relying on cryogenic technologies (e.g., IBM, Google, Quantinuum). The acquisition of Luminar Semiconductor and the development of TFLN chips align with the forecasted 39% CAGR for the TFLN market and 20.5% for the photonic integrated circuit market, positioning QCi to capitalize on these trends. However, the industry remains highly competitive with significant R&D investments from both large tech giants and sovereign nations, posing challenges for QCi's commercialization efforts and market share capture.
Comparison to Industry Standards
- QCi's Entropy Quantum Computer (EQC) operates at room temperature and low power, contrasting with leading quantum computing approaches like superconducting (e.g., IBM, Google), trapped-ion (e.g., Quantinuum, IonQ), and annealing (e.g., D-Wave Quantum) architectures, which typically require cryogenic temperatures and high power.
- The company's focus on integrated photonics and Thin Film Lithium Niobate (TFLN) chips positions it in a rapidly growing segment, with the TFLN market projected to grow from $190.4 million in 2022 to $1.9 billion by 2029 (39% CAGR), and the photonic integrated circuit (PIC) market from $15.1 billion in 2024 to $38.4 billion in 2029 (20.5% CAGR).
- QCi's reservoir computing machines, Emucore and Neurawave, aim to provide faster processing speeds and lower energy consumption for time-dependent tasks compared to certain traditional software implementations, competing with AI/ML hardware solutions from companies like NVIDIA (GPUs) and specialized AI accelerators.
- The company faces competition from diversified global companies with significantly greater financial, technical, and marketing resources such as IBM, Google, Intel, Microsoft, Quantinuum (formerly Honeywell), and Amazon, as well as specialized quantum computing firms like D-Wave Quantum, Rigetti Computing, IonQ, PsiQuantum, Xanadu, and Infleqtion (formerly ColdQuanta).
- QCi's strategy to offer on-premises EQC installations, compatible with standard server room infrastructure, differentiates it from cloud-only quantum computing services offered by many competitors.
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| NA | Dr. William McGann | NA | 2025-04-15 | Separation Agreement and General Release. |
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Policy Adoption | Approved a Non-Employee Director Compensation Policy, effective January 1, 2026, establishing cash retainers and automatic, non-discretionary equity grants (Initial Grant and Annual Grant) with a maximum annual compensation of $230,000. | 2026-01-01 | Aims to attract and retain high-caliber outside directors by providing a competitive and structured compensation package, aligning director incentives with long-term company performance. |
| Internal Control Weaknesses | Identified material weaknesses in internal control over financial reporting as of December 31, 2025, related to the control environment, risk assessment process, and IT general controls. | 2025-12-31 | Indicates a risk of material misstatements in financial statements not being prevented or detected timely. Management is implementing remediation measures, including hiring additional accounting staff and improving controls, to strengthen the control environment. |
| Internal Control Remediation | Remediated previously identified material weaknesses over inadequate controls related to revenue recognition and insufficient written policies and procedures for accounting and financial reporting. | 2025-12-31 | Demonstrates progress in strengthening financial reporting processes and reducing the risk of misstatements in specific areas. |
| Cybersecurity Oversight | The Board, through the Risk Committee, is actively involved in oversight of the company's risk management program, with cybersecurity policies based on NIST, ISO, and other industry standards. | NA | Enhances the company's ability to identify, prevent, mitigate, and respond to cybersecurity threats, protecting intellectual property and operations in a high-tech industry. |
Legal Proceedings
- BV Advisory v. QCi Appraisal Action: Resolved on July 17, 2025, through a Confidential Settlement Agreement and Release, where QCi issued 1,900,000 shares of common stock to Barksdale (BV Advisory's managing member) or his designees, and BV Advisory dismissed its claims.
- BV Advisory v. QCi Breach of Contract Lawsuit: Resolved on July 17, 2025, through the same Confidential Settlement Agreement and Release.
- QCi v. BV Advisory Injunction Lawsuit: Resolved on July 17, 2025, through the same Confidential Settlement Agreement and Release, with QCi dismissing its claims against BV Advisory.
- Securities Class Action Lawsuit: Filed February 25, 2025, alleging violations of Section 10(b) and 20(a) of the Exchange Act for false/misleading statements between March 30, 2020, and January 15, 2025. A second amended complaint was filed on February 13, 2026, and QCi intends to file a motion to dismiss by March 13, 2026.
- Shareholder Derivative Action Lawsuits (March, May, June, September 2025): Multiple lawsuits filed against current and past officers and directors for alleged breaches of fiduciary duties, unjust enrichment, abuse of control, waste of corporate assets, gross mismanagement, and common law fraud. All these actions have been stayed pending the resolution of the company's motion to dismiss the Securities Class Action.
- Arbitration over Stock Options: In February 2025, arbitrations began with two former consultants regarding forfeited stock options. On February 23, 2026, an arbitrator ruled in favor of one consultant on 1 of 7 claims; the award is confidential and immaterial to the company's financial condition. The remaining arbitration is deemed immaterial.
Stakeholder Impact
- Shareholders: Experienced significant dilution from the issuance of 86.3 million shares of common stock in 2025 through private placements. Face risks of stock price volatility, further dilution from future capital raises, and concentrated voting power of executive officers and directors.
- Employees: Increased headcount in R&D and sales staff. Benefit from stock option plans and 401(k) retirement savings plan. Risk of inability to attract and retain highly qualified and skilled employees in a competitive market.
- Customers: Benefit from new product launches (Dirac-3 EQC, Neurawave, vibrometer, quantum networking devices) and the availability of foundry services for TFLN Optical Chips. The company is focused on customer education and providing quantum-ready solutions for complex optimization problems.
- Suppliers: The company's dependence on certain suppliers, particularly for TFLN Optical Chips, with manufacturing concentrated in East Asia, exposes it to geopolitical and supply chain risks that could affect product development and production.
- Creditors: The company repaid the Streeterville Convertible Note in 2024 and has no lines of credit or short-term debt obligations outstanding as of December 31, 2025, indicating a strong current liquidity position.
Next Steps
- Continue to invest in ongoing research and development and go-to-market programs.
- Incur additional integration and scaling costs associated with the Luminar Semiconductor acquisition.
- Invest in the Foundry Services offering, including future expansion of the AZ Chips Facility and the construction or acquisition of a high-volume chip manufacturing facility (FAB 2).
- Accelerate the development of key technologies and products by hiring additional scientists, engineers, and technicians.
- Develop and release a series of additional EQC products (e.g., Dirac-4) in the coming years, with planned enhancements in size, capacity, speed, scalability, and performance fidelity.
- Introduce greater performance and scalability in future generations of the reservoir computing machine to enable participation in LLM training and other applications.
- Migrate product designs based on discrete optical components to photonic integrated circuits built on Thin Film Lithium Niobate (TFLN) wafers.
- Implement and monitor measures to remediate identified material weaknesses in internal control over financial reporting, including hiring additional accounting professionals, documenting procedures, and improving IT general controls.
- File a motion to dismiss the second amended complaint in the securities class action lawsuit on or before March 13, 2026.
- File the proxy statement for the 2026 annual meeting of stockholders within 120 days after December 31, 2025.
Key Dates
| Date | Description |
|---|---|
| 2001-07-25 | Company formed in the State of Nevada under its original name, Ticketcart, Inc. |
| 2009 | Company changed its name to Innovative Beverage Group Holdings, Inc. |
| 2018-02-22 | Company redomiciled to Delaware and changed its name to Quantum Computing Inc. |
| 2018-07-20 | Trading symbol for common stock changed from IBGH to QUBT on the OTC Market. |
| 2020-12-17 | QPhoton signed an Exclusive License Agreement with the Stevens Institute of Technology. |
| 2021-03-01 | QPhoton entered into a Note Purchase Agreement with BV Advisory Partners, LLC. |
| 2021-03-23 | QPhoton and BV Advisory entered into convertible promissory notes. |
| 2021-07-09 | QPhoton and BV Advisory entered into convertible promissory notes. |
| 2021-07-15 | Company uplisted to The Nasdaq Stock Market LLC. |
| 2021-11-10 | Start of private placement offering of Series A convertible preferred stock and warrants. |
| 2021-11-17 | Private placement offering of Series A convertible preferred stock and warrants completed and closed. |
| 2022-02-17 | Board established an executive compensation framework for fiscal year 2026. |
| 2022-02-18 | Company entered into a Note Purchase Agreement with QPhoton and loaned $1.25 million. |
| 2022-04-01 | Company loaned an additional $1.25 million to QPhoton under the QCi Note Purchase Agreement. |
| 2022-04-27 | Company filed a Registration Statement on Form S-3 to register the resale of common stock from Preferred Stock SPAs. |
| 2022-05-18 | Agreement and Plan of Merger by and among Quantum Computing Inc., Project Alpha Merger Sub I, Inc., Project Alpha Merger Sub II, LLC, QPhoton, Inc., and Yuping Huang. |
| 2022-06-02 | SEC declared the Form S-3 effective. |
| 2022-06-15 | Stevens Institute of Technology agreed to assign the license agreement to QCi upon consummation of the QPhoton Merger. |
| 2022-06-16 | QPhoton Merger completed; Company issued 6.3 million QPhoton Warrants. |
| 2022-07-05 | Board of Directors adopted the Quantum Computing Inc. 2022 Equity and Incentive Plan. |
| 2022-07-14 | BV Advisory returned cashier's check and disputed the calculation of the amount paid to settle the notes. |
| 2022-08-16 | BV Advisory filed a complaint in the Delaware Chancery Court alleging breach of the BV Note Purchase Agreement. |
| 2022-09-23 | Company entered into an Unsecured Note Purchase Agreement with Streeterville Capital, LLC. |
| 2022-10-13 | BV Advisory filed a petition in the Delaware Chancery Court seeking appraisal rights on QPhoton shares. |
| 2022-10-28 | Company filed a shelf registration statement on Form S-3. |
| 2022-12-05 | Company entered into an At-the-Market Issuance Sales Agreement with Ascendiant Capital Markets, LLC. |
| 2022-12-01 | Company filed a defamation action in New Jersey Superior Court against BV Advisory and other parties. |
| 2023-01-10 | SEC declared the ATM Agreement amendment effective. |
| 2023-06-06 | Company entered into a note purchase agreement with millionways, Inc. and loaned $500 thousand. |
| 2023-06-01 | QCi launched Emucore, its first AI product (reservoir computing machine). |
| 2023-07-01 | QCi launched its Quantum Photonic Vibrometer. |
| 2023-07-01 | Receivership petition filed by BV Advisory against the Company in the Delaware Chancery Court. |
| 2023-08-17 | Company and Ascendiant entered into an amendment to the ATM Agreement, increasing the amount of common stock to $50 million. |
| 2023-08-18 | Company filed a prospectus supplement for the ATM Upsize. |
| 2023-12-14 | FASB issued Accounting Standard Update (ASU) 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures. |
| 2024-01-01 | QCi launched a new EQC device (Dirac-3) during the first quarter of 2024. |
| 2024-03-19 | Company entered into a Redemption and Waiver Agreement with the current holders of Series A Preferred Stock. |
| 2024-03-01 | Company terminated consulting agreements with two former consultants, leading to stock option forfeiture claims. |
| 2024-05-01 | Defamation action filed by the Company in New Jersey Superior Court in December 2022 was dismissed on procedural grounds. |
| 2024-05-01 | Receivership petition filed by BV Advisory against the Company in July 2023 was dismissed without prejudice. |
| 2024-08-06 | Company entered into a Securities Purchase Agreement with Streeterville Capital, LLC for a Secured Convertible Promissory Note of $8.25 million. |
| 2024-09-01 | Department of Commerce Bureau of Industry and Security (BIS) issued regulations placing controls and licensing requirements on the export of certain quantum computing products and technology. |
| 2024-10-17 | Delaware Chancery Court entered a Stipulation and Order dismissing BV Advisory's claim for breach of the BV Note Purchase Agreement, subject to transfer to Superior Court. |
| 2024-11-12 | BV Advisory filed a new complaint in the Delaware Superior Court asserting breach of the BV Note Purchase Agreement. |
| 2024-11-14 | Company entered into securities purchase agreements for a registered direct offering (November RDO) to sell 16 million shares for $40 million gross proceeds. |
| 2024-11-18 | Company completed the sale of November RDO Shares and repaid the Streeterville Convertible Note for approximately $9.3 million. |
| 2024-12-01 | Former consultants claimed they still retained the right to exercise forfeited stock options. |
| 2024-12-10 | Company entered into securities purchase agreements for a registered direct offering ($7.7 million gross) and a concurrent private placement ($42.3 million gross). |
| 2024-12-12 | The December RDO and December Private Placement closed. |
| 2024-12-20 | Company filed a registration statement for the resale of the December Placement Shares. |
| 2025-01-01 | Company adopted ASU 2023-09, Income Taxes (Topic 740). |
| 2025-01-02 | Company filed a registration statement registering the resale of the January Placement Shares. |
| 2025-01-06 | SEC declared the registration statement for the resale of the December Placement Shares effective. |
| 2025-01-07 | Company entered into securities purchase agreements for a private placement offering (January Private Placement) to sell shares for $100 million gross proceeds. |
| 2025-01-09 | January Private Placement closed. |
| 2025-01-15 | End date of the class period for the securities class action lawsuit. |
| 2025-01-31 | Company filed a complaint in Delaware Chancery Court against BV Advisory and Barksdale asserting claims for defamation, breach of contract, etc. |
| 2025-02-03 | SEC declared the registration statement for the January Placement Shares effective. |
| 2025-02-11 | Court granted the Company's motion for temporary restraining order against BV Defendants. |
| 2025-02-25 | A class action lawsuit was filed against the Company and certain officers in the New Jersey District Court. |
| 2025-03-01 | Company substantially completed the buildout of its AZ Chips Facility. |
| 2025-03-31 | A shareholder derivative action (March 2025 Derivative Action) was filed. |
| 2025-04-15 | Separation Agreement and General Release dated between Quantum Computing, Inc. and Dr. William McGann. |
| 2025-05-06 | A shareholder derivative action (May 2025 Derivative Action) was filed. |
| 2025-06-01 | New Jersey District Court designated a lead plaintiff for the securities class action lawsuit. |
| 2025-06-19 | A shareholder derivative action (June 2025 Derivative Action) was filed. |
| 2025-06-20 | Employment Agreement between Christopher Roberts and Quantum Computing, Inc. |
| 2025-06-22 | Company entered into securities purchase agreements for a private placement (Placement) of shares for $200 million gross proceeds. |
| 2025-06-24 | The Placement closed. |
| 2025-07-03 | Company filed a registration statement providing for the resale of the Placement Shares. |
| 2025-07-06 | Warrants from the January SPAs become exercisable. |
| 2025-07-14 | SEC declared the registration statement for the resale of the Placement Shares effective. |
| 2025-07-17 | Company entered into a Confidential Settlement Agreement and Release with Barksdale and BV Advisory. |
| 2025-07-28 | Company filed a resale registration statement on Form S-1 for the shares issued in the settlement. |
| 2025-07-30 | FASB issued ASU 2025-05, Financial Instruments Credit Losses (Topic 326): Measurement of Credit Losses for Accounts Receivable and Contract Assets. |
| 2025-08-04 | SEC declared the resale registration statement effective. |
| 2025-08-26 | Lead plaintiff filed an amended operative complaint in the securities class action lawsuit. |
| 2025-09-21 | Company entered into securities purchase agreements for a private placement (September Placement) of shares for $500 million gross proceeds. |
| 2025-09-24 | September Private Placement closed. |
| 2025-09-25 | A shareholder derivative action (September 2025 Derivative Action) was filed. |
| 2025-10-01 | Company filed a registration statement on Form S-3ASR for the September Placement Shares. |
| 2025-10-05 | Company entered into securities purchase agreements for a private placement (October Placement) of shares for $750 million gross proceeds. |
| 2025-10-08 | October Placement closed. |
| 2025-10-10 | Company filed a registration statement on Form S-3ASR for the October Placement Shares. |
| 2025-11-14 | Company filed a motion to dismiss the amended operative complaint in the securities class action lawsuit. |
| 2025-11-01 | Company launched Neurawave, a photonics-based reservoir computer. |
| 2025-12-15 | Company entered into a Stock Purchase Agreement with Luminar Technologies, Inc. and Luminar Semiconductor, Inc. for a $110 million acquisition. |
| 2025-12-16 | Employment Agreement between Quantum Computing Inc. and Yuping Huang. |
| 2025-12-18 | Non-Employee Director Compensation Policy approved by the Board. |
| 2025-12-01 | FASB issued ASU No. 2025-11, Interim Reporting (Topic 270): Narrow-Scope Improvements. |
| 2025-12-31 | Fiscal year ended. |
| 2026-01-01 | Non-Employee Director Compensation Policy became effective. |
| 2026-02-02 | Luminar Acquisition completed. |
| 2026-02-13 | Lead plaintiff filed a second amended complaint in the securities class action lawsuit. |
| 2026-02-23 | Arbitrator ruled in favor of one former consultant on 1 of 7 claims regarding stock options. |
| 2026-02-27 | 224,538,254 shares of common stock issued and outstanding. |
| 2026-03-02 | Annual Report on Form 10-K dated. |
| 2026-03-13 | Company's motion to dismiss the second amended complaint in the securities class action lawsuit is due. |
| 2026-03-31 | Termination right for Luminar acquisition if not consummated by this date. |
| 2026-12-15 | Effective date for ASU 2024-03 for annual periods for public entities. |
| 2027-02-02 | Escrowed amount for Luminar acquisition indemnification obligations to be released. |
| 2027-12-15 | Effective date for ASU 2024-03 for interim periods for public entities. |
| 2028-01-01 | Effective date for ASU 2025-11 for interim periods. |
| 2028-05-31 | Most of the principal office lease in Hoboken, NJ, ends. |
| 2028-08-31 | Lease for the Bedford, MA facility expires. |
| 2028-11-30 | Lease for the Tempe, AZ facility ends. |
| 2028-03-31 | Lease for the Cranbury, NJ facility expires. |
| 2030-01-30 | Lease for the Wilmington, MA facility expires. |
| 2030-07-31 | A portion of the principal office lease in Hoboken, NJ, ends. |
| 2041-12-23 | Anticipated expiration date for US Patent 11,436,519 ('Machine Learning Mapping for Quantum Processing Units'). |
Recommendation
holdStockSavvy.ai recommends a "hold" for Quantum Computing Inc. The company demonstrated strong revenue growth in 2025, particularly in product sales, and successfully secured a substantial $1.475 billion in capital, providing a significant financial runway for its ambitious R&D and commercialization efforts. The strategic acquisition of Luminar Semiconductor enhances its vertical integration and technological capabilities in the high-growth photonics market. However, QCi remains an early-stage company with an unproven business model, persistent operating losses, and identified material weaknesses in internal financial controls, which require diligent remediation. The highly competitive quantum computing landscape and ongoing legal challenges introduce considerable uncertainty. While the long-term potential of its photonics-based quantum technology is compelling, the immediate future is marked by both significant opportunities and substantial execution risks, warranting a cautious stance for investors.
Keywords
Quantum Computing, Photonics, Quantum Optics, AI, Machine Learning, Remote Sensing, Cybersecurity, TFLN, Lithium Niobate, Entropy Quantum Computer, Dirac, Neurawave, LiDAR, Quantum Photonic Vibrometer, Quantum Authentication, SEC Filing, 10-K, Financial Report, Technology, Hardware, Software, Semiconductor, Acquisition, Luminar Semiconductor, Corporate Governance, Risk Management
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.